This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Eisai R&d Management Co., Ltd., Sogo Pharmaceutical Co., Ltd., Shizuoka Prefectural University Corporation. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 530 
3 out of 21 
1 out of 9 Years Active: 2018-2026
Title: **Innovator Spotlight: Yohei Tanaka**
Introduction
Yohei Tanaka, a prominent inventor based in Nakama, Japan, has made significant contributions to the field of biochemistry and pharmaceutical sciences. With a total of three patents to his name, Tanaka is dedicated to developing innovative solutions for nucleic acid delivery, which has important implications for medical treatments.
Latest Patents
Among his latest inventions, Tanaka has developed a novel cationic lipid designed for efficient nucleic acid delivery to the cytoplasm. This invention addresses the challenge of physical stability in lipid complexes, offering a potential improvement in therapeutic delivery systems. The cationic lipid is represented by a general formula that includes an alkyl or alkenyl group with 7-12 carbon atoms and specific alkyl chains for optimized performance. His work is pivotal in advancing the methods of delivering nucleic acid therapies.
Career Highlights
Throughout his career, Yohei Tanaka has worked with esteemed companies, including Eisai R&D Management Co., Ltd. and Sogo Pharmaceutical Co., Ltd. His expertise in the area of pharmaceuticals and his innovative approach have earned him recognition in the industry. He is known for his commitment to research and development, focusing on the creation of effective therapeutic solutions.
Collaborations
Tanaka has collaborated with talented colleagues such as Yuta Suzuki and Kenji Hyodo, contributing to a collaborative environment that fosters innovation and scientific advancement. Together, they have explored various avenues in pharmaceutical research, enhancing the potential applications of their inventions.
Conclusion
In summary, Yohei Tanaka represents a remarkable figure in the realm of innovation, particularly in the development of cationic lipids for nucleic acid delivery. His contributions have the potential to revolutionize therapeutic approaches, making him a notable inventor in his field. As he continues to pursue advancements in his research, the impact of his work will undoubtedly be felt in the medical community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile